A post-market study (ELEVATE registry) of the fully magnetically levitated continuous flow HeartMate III left ventricular assist device (LVAD) found no pump thrombosis in 463 patients in Europe and Kazakhstan.
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Heart Failure - Congestive
Six-Month Outcomes After Treatment of Advanced Heart Failure With a Full Magnetically Levitated Continuous Flow Left Ventricular Assist Device: Report From the ELEVATE Registry
October 23, 2018
July 23, 2018
Ma and colleagues evaluated left ventricular diastolic function in 183 patients who had undergone isolated aortic valve replacement for severe aortic regurgitation. Echocardiographic data was used to evaluate the relationship between preoperative diastolic function and postoperative mortality and cardiac function.
July 6, 2018
A detailed and somewhat disheartening analysis of stem cell therapy for cardiac failure.
The Incidence and Consequence of Prosthesis-Patient Mismatch After Surgical Aortic Valve Replacement
July 3, 2018
Fallon and colleagues evaluated patient-prosthesis mismatch (PPM) following isolated aortic valve replacement reported in the STS Adult Cardiac Surgery Database. They found that both moderate and severe PPM were associated with worse outcomes compared to no PPM over the 10-year study period.
May 15, 2018
A sober editorial on a murine model of induced cardiac failure, which highlights the challenges of translating animal omics to humans
March 27, 2018
A succinct balanced editorial advancing, amongst other things, the position for initial nonintervention for submassive pulmonary embolism.
March 12, 2018
An interesting two-year report from the MOMENTUM 3 randomized controlled trial comparison of HeartMate 3 and II, the analysis performed by Abbott. Although stroke and reoperation were clearly lower with the latest technology, reflected in the lower LDH measurements, there was bafflingly no improvement in survival.
March 1, 2018
A 16-year retrospective analysis of cardiac transplantation outcomes, recommending cold ischemic times of less than two hours for older donors.
Selective Implantation of Durable Left Ventricular Assist Devices as Primary Therapy for Refractory Cardiogenic Shock
February 28, 2018
A retrospective Mount Sinai small series on selective emergent implantation of long-term ventricular assist devices in cardiogenic shock. It challenges the traditional concept of short-term stabilisation with ECMO or short-term support, and is likely to generate criticism and discussions.
February 2, 2018
An editorial from an influential source discussing the recent robust results of the CASTLE-AF RCT trial. It is likely that interventions for atrial fibrillation will be boosted by these results, in terms of insurance, industry, and clinical guideline support.